Therapeutic Targets Database
BIDD Pharmainformatics Databases
 
   
 

 

TTD Drug ID: DAP000180

Drug Information
NameOmeprazole    
SynonymsO0359; Inhibitron; Esomeprazole; SMR000058847; Gibancer; omeprazole; Ortanol; Omeprazole magnesium; CID4594; Elgam; Exter; I06-0705; Prestwick2_000493; LS-7629; Omeprazole delayed-release; HMS2090E16; Emeproton; Zepral; OMEP; Prazolit; AGI-010; Omepradex; Proclor; Prestwick1_000493; O104_SIGMA; Omeprazone; C07324; H 168-68; NCGC00021522-03; 131959-78-9; AC1L1IIJ; UNII-KG60484QX9; Osiren; Omizac; Procelac; Omeprazolum; BPBio1_000425; BIDD:GT0189; Losec, Omesec, Prilosec, Zegerid, Omeprazole; Ulcometion; Omepral; CHEMBL1503; Dizprazol; 6-methoxy-2-[(4-methoxy-3,5-dimethylpyridin-2-yl)methylsulfinyl]-1H-benzimidazole; Inhipump; Ulsen; Prilosec; Prysma; Omezol; 5-Methoxy-2[(4-methoxy-3,5-dimethyl-2-pyridyl)methylsulfinyl]-1H-benzimidazole; Paprazol; Nilsec; Bio-0888; Ceprandal; Nexium; Zefxon; Peptilcer; Prilosec OTC; HMS2052G17; Omez; 2-({[3,5-dimethyl-4-(methyloxy)pyridin-2-yl]methyl}sulfinyl)-5-(methyloxy)-1H-benzimidazole; Omeprazon; AKOS005066653; CHEBI:519601; MLS000069373; Tedec Ulceral; Miracid; Omegast; Pepticus; Lomac; HMS1569D07; DB00736; Omeprol; UPCMLD-DP075:001; Ozoken; MolPort-003-849-702; Axagon; AC-401; HMS2090F11; Maybridge4_002645; Miol; Omebeta; H168/68; Secrepina; Olit; BRD-A55962179-001-04-9; CAS-73590-58-6; NCGC00021522-04; UPCMLD-DP075; Mepral; Esomperazole; H 168/68; SAN-15; Mopral; Omeprazol; CCRIS 7099; Gastroloc; TL8005099; Omapren; Omed; IDI1_032523; Morecon; Omeprazole [USAN:INN:BAN:JAN]; Losec; Omid; Ocid; Prestwick0_000493; Nopramin; SPBio_002306; BSPBio_000385; MolPort-003-666-741; Esopral; S1389_Selleck; Lucen; 5-Methoxy-2-[[(4-methoxy-3,5-dimethyl-2-pyridinyl)methyl]sulfinyl]-1H-benzimidazole; Omesek; Belmazol; MLS001076112; CPD000058847; NCGC00021522-05; Gastrimut; NCGC00016925-01; Nuclosina; esomeprazol; Parizac; H-168/68; Antra MUPS; 73590-58-6; DB00338; Lensor; Zimor; Gasec; Ramezol; Danlox; Desec; 5-methoxy-2-{[(4-methoxy-3,5-dimethylpyridin-2-yl)methyl]sulfinyl}-1H-benzimidazole; 172964-80-6; Epirazole; Prestwick3_000493; Ulcsep; 119141-89-8; Audazol; Ulzol; Indurgan; Prazidec; MolPort-003-807-515; Antra; 5-Methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridyl)methyl)sulfinyl)benzimidazole; HSDB 3575; HMS1528I05; Prestwick_808; Demeprazol; ( -)-Omeprazole; Pepticum; Omebeta 20; Omezolan; Ulceral; Result; Prazentol; Nexium IV; Olexin; Omisec; DM-3458; Regulacid; SAM001246900; OMZ; Ultop; MLS001424148; Logastric; Zegerid; Omeprazolum [INN-Latin]; Omeprazole (JAN/USP/INN); Ulcesep; 2-(((3,5-Dimethyl-4-methoxy-2-pyridyl)methyl)sulfinyl)-5-methoxy-1H-benzimidazole; Omeprazol [INN-Spanish]; Dudencer; NCGC00016925-02; STK623746; Erbolin; Sanamidol; CHEBI:7772; 1H-Benzimidazole, 5-methoxy-2-(((4-methoxy-3,5-dimethyl-2-pyridinyl)methyl)sulfinyl)-; Ulcozol; Victrix; Prilosec (TN); Emilok; AULCER; Ompanyt; D00455; Zoltum    
Trade NameLosec; Prilosec    
CompanyAstraZeneca    
IndicationGastroesophageal reflux diseaseApproved    [1]
Structure

Click to save drug structure in 3D MOL format

Click to save drug structure in 2D MOL format
   
Therapeutic ClassAnti-Ulcer Agents    
CAS NumberCAS 73590-58-6
FormularC17H19N3O3S    
PubChem Compound IDCID 4594.    
PubChem Substance IDSID 9532.    
ChEBI7772;    
SuperDrug ATC IDA02BC01;    
SuperDrug CAS ID073590586;    
TargetProton pumpInhibitor[2][3][4]
Ref 1Generic omeprazole delayed-release capsules: in vitro performance evaluations. Drug Dev Ind Pharm. 2009 Aug;35(8):917-21. To Reference
Ref 2Nat Rev Drug Discov. 2003 Jan;2(1):38-51.Knockouts model the 100 best-selling drugs--will they model the next 100? To Reference
Ref 3Proton pump inhibition. An effective, safe approach to GERD management. Postgrad Med. 2001 Oct;Spec No:24-35. To Reference
Ref 4Apical membrane localization of ouabain-sensitive K(+)-activated ATPase activities in rat distal colon. Am J Physiol. 1991 Dec;261(6 Pt 1):G1005-11. To Reference



 

Welcome to sign our Guestbook.

If you find any error in data or bug in web service, please kindly report it to Dr. Zhu.


Dr. Chen Yuzong
Deputy Director of Center for Computational Science and Engineering
Professor in Department of Pharmacy
National University of Singapore, Singapore


All rights reserved.

 
   
           
 
Computer-aided Drug Design
About BIDD | Databases | Software | Teaching | Research |  Links

Department of Computational Science | National University of Singapore | Blk S17, 3 Science Drive 2, Singapore 117543